ScholarLens Back to search
2006•Unpublished venueRequires access

Clinical Observation on the treatment for Hyperbilirubinemia of Viral Hepatitis with Matrine combined with higher doses Danshen Injection

Zhao Yu-liang

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and safety of the treatment for Hyperbilirubinemia of Viral Hepatitis with Matrine combined with higher doses Danshen Injection.Methods 60 patients with hyperbilirubinemia of viral hepatitis randomly divided into treatment group and control group. In the control group every patient was given diammonium Glycyrrhizinate?Potassium Magnesium Aspartate Injection?TAD?Human Albumin?Blood Plasma etc. In the treatment group every patients was given Matrine (150mg/d) combined with Danshen Injection (40ml/d) additionally.Results During the treatment of 4 weeks, all patients showed decreased serum TBil?ALT and PT. In the treatment group, the rates of decreased serum TBil and PT significantly higher than those in the control group(P0.01).Conclusion Matrine combined with higher doses Danshen Injection has satisfied efficacy and safety in treatment for Hyperbilirubinemia of Viral Hepatitis.

About this research paper

What this paper is about

Objective To evaluate the efficacy and safety of the treatment for Hyperbilirubinemia of Viral Hepatitis with Matrine combined with higher doses Danshen Injection.Methods 60 patients with hyperbilirubinemia of viral hepatitis randomly divided into treatment group and control group. In the control group every patient was given diammonium Glycyrrhizinate?Potassium Magnesium Aspartate Injection?TAD?Human Albumin?Blood Plasma etc. In the treatment group every patients was given Matrine (150mg/d) combined with Danshen Injection (40ml/d) additionally.Results During the treatment of 4 weeks, all patients showed decreased serum TBil?ALT and PT. In the treatment group, the rates of decreased serum TBil and PT significantly higher than those in the control group(P0.01).Conclusion Matrine combined with higher doses Danshen Injection has satisfied efficacy and safety in treatment for Hyperbilirubinemia of Viral Hepatitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and safety of the treatment for Hyperbilirubinemia of Viral Hepatitis with Matrine combined with higher doses Danshen Injection.Methods 60 patients with hyperbilirubinemia of viral hepatitis randomly divided into treatment group and control group. In the control group every patient was given diammonium Glycyrrhizinate?Potassium Magnesium Aspartate Injection?TAD?Human Albumin?Blood Plasma etc. In the treatment group every patients was given Matrine (150mg/d) combined with Danshen Injection (40ml/d) additionally.Results During the treatment of 4 weeks, all patients showed decreased serum TBil?ALT and PT. In the treatment group, the rates of decreased serum TBil and PT significantly higher than those in the control group(P0.01).Conclusion Matrine combined with higher doses Danshen Injection has satisfied efficacy and safety in treatment for Hyperbilirubinemia of Viral Hepatitis.

Key concepts: Matrine, Medicine, Albumin, Viral hepatitis, Internal medicine, Gastroenterology, Hepatitis a virus, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Observation on the treatment for Hyperbilirubinemia of Viral Hepatitis with Matrine combined with higher doses Danshen Injection — Research Paper | ScholarLens